» Articles » PMID: 28144039

Role of KCNB1 in the Prognosis of Gliomas and Autophagy Modulation

Overview
Journal Sci Rep
Specialty Science
Date 2017 Feb 2
PMID 28144039
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Increasing evidence suggests that ion channel genes play an important role in the progression of gliomas. However, the mechanisms by which ion channel genes influence the progression of glioma are not fully understood. We identified KCNB1 as a novel ion gene, associated with malignant progression and favorable overall survival (OS) and progression-free survival (PFS) in glioma patients from three datasets (CGGA, GSE16011 and REMBRANDT). Moreover, we characterized a novel function of autophagy induction accompanied by increased apoptosis and reduced proliferation and invasion of glioma cells for KCNB1. KEGG pathway analysis and in vitro studies suggested that the ERK pathway is involved in KCNB1-mediated regulation of autophagy, which was confirmed by inhibition of KCNB1-induced autophagy by using a selective ERK1/2 inhibitor (U0126) or siERK1/2. In vivo studies showed that KCNB1 induced autophagy while inhibiting tumor growth and increasing survival. Overall, our studies define KCNB1 as a novel prognostic factor for gliomas that exerts its tumor suppressive function through autophagy induction.

Citing Articles

Neurons as stromal drivers of nervous system cancer formation and progression.

Anastasaki C, Gao Y, Gutmann D Dev Cell. 2023; 58(2):81-93.

PMID: 36693322 PMC: 9883043. DOI: 10.1016/j.devcel.2022.12.011.


Comprehensive Genomic and Epigenomic Analyses on Transcriptomic Regulation in Stomach Adenocarcinoma.

Chen J, Liu W, Du J, Wang P, Wang J, Ye K Front Genet. 2022; 12:778095.

PMID: 35222516 PMC: 8873582. DOI: 10.3389/fgene.2021.778095.


Identification and validation of potential novel prognostic biomarkers for patients with glioma based on a gene co-expression network.

Jiang Y, Wang R, Zhuang Y, Chen C Transl Cancer Res. 2022; 9(10):6444-6454.

PMID: 35117252 PMC: 8798165. DOI: 10.21037/tcr-20-492.


A Genome-Wide Profiling of Glioma Patients with an IDH1 Mutation Using the Catalogue of Somatic Mutations in Cancer Database.

Pappula A, Rasheed S, Mirzaei G, Petreaca R, Bouley R Cancers (Basel). 2021; 13(17).

PMID: 34503108 PMC: 8428353. DOI: 10.3390/cancers13174299.


Reduced Graphene Oxides Modulate the Expression of Cell Receptors and Voltage-Dependent Ion Channel Genes of Glioblastoma Multiforme.

Szczepaniak J, Jagiello J, Wierzbicki M, Nowak D, Sobczyk-Guzenda A, Sosnowska M Int J Mol Sci. 2021; 22(2).

PMID: 33419226 PMC: 7825604. DOI: 10.3390/ijms22020515.


References
1.
Stupp R, Hegi M, Mason W, van den Bent M, Taphoorn M, Janzer R . Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 2009; 10(5):459-66. DOI: 10.1016/S1470-2045(09)70025-7. View

2.
Ryland K, Svoboda L, Vesely E, McIntyre J, Zhang L, Martens J . Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress. Oncogene. 2014; 34(35):4591-600. PMC: 4451446. DOI: 10.1038/onc.2014.384. View

3.
Malin S, Nerbonne J . Delayed rectifier K+ currents, IK, are encoded by Kv2 alpha-subunits and regulate tonic firing in mammalian sympathetic neurons. J Neurosci. 2002; 22(23):10094-105. PMC: 6758768. View

4.
DAlessandro G, Catalano M, Sciaccaluga M, Chece G, Cipriani R, Rosito M . KCa3.1 channels are involved in the infiltrative behavior of glioblastoma in vivo. Cell Death Dis. 2013; 4:e773. PMC: 3763441. DOI: 10.1038/cddis.2013.279. View

5.
Bonnet S, Archer S, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R . A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell. 2007; 11(1):37-51. DOI: 10.1016/j.ccr.2006.10.020. View